Title: Marchiafavae Bignami Disease in Chronic Alcoholic Patient

Authors: Kiran Bheemeshwar, Chaitra Sunil

 DOI:  https://dx.doi.org/10.18535/jmscr/v6i1.176

Abstract

Marchiafava-Bignami disease (MBD) is a rare, alcohol-associated disorder characterized by demyelination and necrosis of the corpus callosum. It is mostly seen in male alcoholics. It is caused by the combination of alcohol abuse with malnutrition, leading to metabolic, toxic, and vascular disturbances. MBD carries poor prognosis. There are 2 clinical subtypes- TYPE A where patient mainly presents with coma and stupor has a mortality of 90%; TYPE B, which of lesser severity and presents with only mild mental impairment. Clinical symptoms include reduced consciousness, psychotic and emotional symptoms, depression and apathy, aggression. Diagnosis of the disease is made on the basis of clinical findings in combination with neuro imaging. Treatment options tried include thiamine, folate and VITAMIN B12, amantadine and high dose corticosteroids have been tried with limited success.

We present a patient who presented with acute onset symptoms and typical Imaging findings findings.

References

  1. Heinrich A, Runge U, Khaw AV. Clinicoradiologic subtypes of Marchiafava Bignami disease. J Neurol2004;251:1050–59
  2. Menegon P, Sibon I, Pachai C, et al. Marchiafava-Bignami disease: diffusion weighted MRI in corpus callosum and cortical lesions. Neurology 2005;65:475–77
  3. Kohler CG, Ances BM, Coleman AR, etal. Marchiafava Bignami disease: literature review and case report. Neuropsychiatry Neuropsychol Behav Neurol 2000;13:67–76
  4. Friese SA, Bitzer M, Freudenstein D, et al. Classification of acquired lesions of the corpus callosum with MRI. Neuroradiology 2000;42:795–802
  5. Bourekas EC, Varakis K, Bruns D, Christoforidis GA, Baujan M, Slone HW, et al . Lesions of the corpus callosum: MR imaging and differential considerations in adults and children. AJR Am J Roentgenol 2002;179:251–7.
  6. Chua GC, Sitoh YY, Lim CC, Chua HC, Ng PY. MRI findings in osmotic myelinolysis. Clin Radiol 2002;57:800-6.
  7. Staszewski J, Macek K, Stepien A. Reversible demyelinisation of corpus callosum in the course of Marchiafava-Bignami disease. Neurol Neurochir Pol 2006;40:156-61.
  8. Kikkawa Y, Takaya Y, Niwa N. A case of Marchiafava-Bignami disease that responded to high-dose intravenous corticosteroid administration. Rinsho Shinkeigaku 2000;40:1122-5.

Corresponding Author

Kiran Bheemeshwar

3rd Year Junior Resident, Dept of Medicine,

AIMS B G Nagar nagamangala, Mandya 571448 Karnataka India